Yoneda T - Search Results

1

A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.

Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, Yoneda T, Isoe T. Ohno H, et al. Among authors: yoneda t. Mol Cancer Ther. 2006 Nov;5(11):2634-43. doi: 10.1158/1535-7163.MCT-05-0313. Mol Cancer Ther. 2006. PMID: 17121910

2

Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.

Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2007 May 1;67(9):4157-63. doi: 10.1158/0008-5472.CAN-06-2355. Cancer Res. 2007. PMID: 17483326

3

C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.

Myoui A, Nishimura R, Williams PJ, Hiraga T, Tamura D, Michigami T, Mundy GR, Yoneda T. Myoui A, et al. Among authors: yoneda t. Cancer Res. 2003 Aug 15;63(16):5028-33. Cancer Res. 2003. PMID: 12941830

4

Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.

Hiraga T, Myoui A, Choi ME, Yoshikawa H, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2006 Feb 15;66(4):2067-73. doi: 10.1158/0008-5472.CAN-05-2012. Cancer Res. 2006. PMID: 16489006

5

Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer.

Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Int J Cancer. 2003 Oct 10;106(6):973-9. doi: 10.1002/ijc.11330. Int J Cancer. 2003. PMID: 12918079

6

Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases.

Hiraga T, Myoui A, Hashimoto N, Sasaki A, Hata K, Morita Y, Yoshikawa H, Rosen CJ, Mundy GR, Yoneda T. Hiraga T, et al. Among authors: yoneda t. Cancer Res. 2012 Aug 15;72(16):4238-49. doi: 10.1158/0008-5472.CAN-11-3061. Epub 2012 Jun 27. Cancer Res. 2012. PMID: 22738911 Free PMC article.

7

E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.

Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. Mbalaviele G, et al. Among authors: yoneda t. Cancer Res. 1996 Sep 1;56(17):4063-70. Cancer Res. 1996. PMID: 8752180

8

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma.

Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Yoneda T, et al. Cancer. 2000 Jun 15;88(12 Suppl):2979-88. doi: 10.1002/1097-0142(20000615)88:12+<2979::aid-cncr13>3.0.co;2-u. Cancer. 2000. PMID: 10898341 Review.

9

Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.

Hiraki A, Ueoka H, Bessho A, Segawa Y, Takigawa N, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M. Hiraki A, et al. Among authors: yoneda t. Cancer. 2002 Oct 15;95(8):1706-13. doi: 10.1002/cncr.10828. Cancer. 2002. PMID: 12365018 Free article.

10

Experimental bone metastasis model of the oral and maxillofacial region.

Sasaki A, Yoneda T, Terakado N, Alcalde RE, Suzuki A, Matsumura T. Sasaki A, et al. Among authors: yoneda t. Anticancer Res. 1998 May-Jun;18(3A):1579-84. Anticancer Res. 1998. PMID: 9673373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,012 results

Search Page

Filters